Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.1K
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

2.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
2.9K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

214
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
214
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

6.4K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.4K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

38
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
38
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the Editor Concerning Stram et al.: "Lung Cancer in the Mayak Workers Cohort: Risk Estimation and Uncertainty Analysis." Radiat Res 2021; 195:334-46.

Radiation research·2021
Same author

Dose-response Analysis in the Presence of Shared and Unshared Uncertainties of the Dose Values.

Health physics·2019
Same author

The two-dimensional Monte Carlo: a new methodologic paradigm for dose reconstruction for epidemiological studies.

Radiation research·2014
Same author

How to account for uncertainty due to measurement errors in an uncertainty analysis using Monte Carlo simulation.

Health physics·2008
Same author

Hypothesis testing, statistical power, and confidence limits in the presence of epistemic uncertainty.

Health physics·2007

Related Experiment Video

Updated: May 25, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.6K

Discrete Bayesian Dose-response Analysis under Dose Uncertainty.

Eduard Hofer1

  • 13 Constance Road, Claremont, Cape Town 7708, South Africa.

Health Physics
|February 26, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new Bayesian model averaging method for dose-response analysis, improving computational efficiency. The method accurately estimates disease-risk relationships by accounting for dose uncertainties in large populations.

Keywords:
dose assessmentepidemiologyrisk estimatessampling

More Related Videos

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

1.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K

Related Experiment Videos

Last Updated: May 25, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.6K
Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

1.3K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Statistical modeling

Background:

  • Establishing disease-risk relationships requires accurate individual dose data.
  • Dose assessment models often contain uncertainties (epistemic uncertainties) in parameters, formulations, and input data.
  • These uncertainties necessitate expressing dose values using joint subjective probability distributions.

Purpose of the Study:

  • To develop a computationally efficient Bayesian model averaging method for dose-response analysis.
  • To address the complexities of traditional Bayesian methods in handling dose uncertainties.
  • To correct for the attenuation effect caused by using estimated dose vectors.

Main Methods:

  • A novel Bayesian model averaging approach operating on a discretized parameter space.
  • Incorporation of joint subjective probability distributions to account for shared uncertainties in dose values.
  • Application of Bayes' theorem and averaging of posterior parameter distributions.

Main Results:

  • The new method demonstrates significant computational efficiency compared to standard Bayesian techniques.
  • It effectively corrects for the attenuation effect in dose-response estimations.
  • Results show comparable accuracy to methods using true dose vectors.

Conclusions:

  • The proposed computationally efficient Bayesian method enhances dose-response analysis by managing epistemic uncertainties.
  • This approach offers a practical solution for complex epidemiological studies involving dose reconstruction.
  • It provides a robust framework for estimating disease-risk relationships with improved accuracy and efficiency.